Prognostic Factors of Patients With COVID-19
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Enrollment
- 201
- Locations
- 1
- Primary Endpoint
- all-cause mortality
Study Overview
Brief Summary
The outbreak of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in China has been declared a public health emergency of international concern. Despite lower mortality rate, SARS-CoV-2 has killed more people than SARS and MERS and the number keeps growing. Epidemic studies have been well described clinical features of patients with COVID-19, with the disease severity being an independent predictor of poor outcome. However, there is still no research investigating the prognostic factors of patients with COVID-19.
Study Design
- Study Type
- Observational
- Observational Model
- Cohort
- Time Perspective
- Retrospective
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Adult aged >=18years old;
- •Diagnosed with CONVID
- •Diagnostic criteria including: Laboratory (RT-PCR) confirmed SARS-Cov-2 infection; CT of the lung conformed to the manifestation of viral pneumonia.
- •Criteria for severe or critical ill conditions: Respiratory rate >=30/min; or Rest SPO2<=93%; or PaO2/FiO2<=300mmHg.
Exclusion Criteria
- •Near-death state (expected survival time less than 24 hours);
- •Malignant tumor;
- •Pregnancy or puerperium women;
- •Patients who refused to participant.
Outcomes
Primary Outcomes
all-cause mortality
Time Frame: 30 days
Secondary Outcomes
- all-cause mortality(15 days)
- Severe state(15 days)
Investigators
Dongying Zhang
Clinical Professor
Chongqing Medical University
